Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Abbott Laboratories

NYSE: ABT · Life Sciences · 5 alerts · CIK 1800

Share price
$107.45Close, Nov 16
Market cap
$186B
Shares outstanding
1.73BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Abbott Laboratories filings on SEC EDGAR ↗

4:14 PM ET 10-Q
Financial Results

Abbott Laboratories Q3 2026 Results: Net Income $920M, Down 44.0% YoY

Abbott Laboratories completed the $20.6 billion acquisition of Exact Sciences in March 2026, significantly expanding its cancer diagnostics portfolio. The company reported net earnings allocated to common shares of $2.9 billion for the first nine months of 2026, while managing a contract liability balance of $669 million and a goodwill increase to $32.6 billion.

Key figure
Net income $920M · -44.0% YoY
7:36 AM ET 8-K
Financial Results

Abbott Laboratories Financial Results

Abbott Laboratories reported third-quarter 2026 sales of $13.01 billion, a 14.5% increase on a reported basis, driven by strong performance in its Diagnostics and Medical Devices segments. The company tightened its full-year 2026 adjusted diluted EPS guidance to a range of $5.50 to $5.55 and highlighted several new product approvals, including the Libre Duo biowearable sensor.

Term
Q3 2026

“Abbott delivered strong third-quarter results, reflecting balanced growth across our portfolio. With strong performance across multiple businesses and a robust pipeline of innovation, we are well-positioned to deliver sustainable growth in the years ahead.”

Robert B. Ford, chairman and chief executive officer, Abbott

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.